PKD2 and pancreatic neoplasm: When investigating such a possibility we found that overexpression of STK33 was paralleled by an augmented PKD2 expression and activity particularly in MIA PaCa2 pancreatic cancer cells as demonstrated by the western blot analysis (Figure 7A).